Transformative Effect of Regenerative Medicine on Human Health Benefits Global Market

Regenerative medicine, according to the US National Institutes of Health (NIH), is the process of developing functional tissues for the repair and/or replacement of damaged organs or tissues. Having lost function due to disease, congenital defects, and age, these tissues or organs are regenerated to establish and restore normal function. 

Regenerative medicine is used in a wide range of applications including neurology, musculoskeletal, cardiovascular, and orthopedic. Earlier this month, a study showed that a new regenerative medicine appears to relieve eye pain, light sensitivity, and burning, and stimulate faster tissue repair following eye surgery. Findings by a team of researchers in Turkey suggest that this new compound can be beneficial for all those patients who undergo refractive surgery and corneal implants.

The regenerative medicine market is a rapidly developing segment of medical science and a report by Transparency Market Research indicates that the global regenerative medicine market is poised to expand at a strong CAGR of 12.80% from 2013 to 2019.

Browse Full Report: http://www.transparencymarketresearch.com/regenerative-medicines-market.html

Ongoing Trends Reflected in the Regenerative Medicine Market 

There a number of factors that not only drive or challenge the global regenerative medicine market but also characterize its presence in the overall field of medical science. 

• One of the most significant forces working in favor of the regenerative medicine market is technological advancements in stem cell therapy and tissue engineering.

• The prevalence of joint and bone disorders has increased in recent years, fueled by the rise in the aging population, increasing prevalence of arthritis, and surge in sports injuries. This, in turn, has given a boost to the regenerative medicine market.

• Strong demand and presence of favorable reimbursement policies has spurred the development of biomaterials technology, rendering it the largest technology segment of the regenerative medicine market.

• The widening range of applications of tissue engineering in improving or replacing biological functions is anticipated to drive the demand for tissue engineering in the coming years. 

• Regenerative medicine is most commonly used in substituting bone grafts and this application segment has flourished owing to the rise in orthopedic surgeries.

• North America serves as the leading regional market for regenerative medicine owing to surging demand for joint and bone reconstructive surgeries and favorable government initiatives.

• Europe, also a major market, is fueled by the rise in geriatric population, which is more prone to arthritis, and extensive funding from the government to support the research and development of regenerative medicine.

• Asia Pacific has been identified as the most promising market for regenerative medicine, driven by the rising demand for bone graft substitutes and expansion of product manufacturers in countries such as China, South Korea, India, and Japan. 

Browse Press Release: http://www.transparencymarketresearch.com/pressrelease/regenerative-medicines-market.htm

Even with these prominent factors driving the regenerative medicine market, post-implantation rejection, ethical issues related to stem cell therapy and tissue engineering, and stringent regulatory compliance threaten to curb the development of the regenerative medicine market. 

Japan Leads APAC Regenerative Medicines Market’s March

Regenerative medicine consists of several techniques and processes used to rebuild lost tissues in the body. It is a fairly new development in the healthcare sector and has only recently grown to a global scale. Thanks to steady advances in medical technology over the past few years, the growth of the regenerative medicines market has been swift. The increased convenience they present to both patients and doctors has resulted in growing demand for the same.

Transparency Market Research, a leading market intelligence company, has predicted that the global regenerative medicine will reach a total valuation of about US$6.5 bn by 2019, at a 12.8% CAGR from 2013.

Browse Research Report:http://www.transparencymarketresearch.com/regenerative-medicines-market.html

Government Support for Regenerative Medicine Growing in Asia Pacific

Currently, North America and Europe lead the global regenerative medicine market, thanks to the strong healthcare infrastructure in countries such as the U.S., Canada, and most EU countries. The affluence of the average consumer in these countries has also helped the regenerative medicines market thrive in these regions.

In the coming years, though, Asia Pacific is expected to rise to the forefront in the global regenerative medicines market. The rapid development of countries such as China, India, and South Korea, allied to existing major economies such as Japan and Australia will allow regenerative medicine manufacturers to establish a strong supply chain in this region. Due to the demonstrable benefits of regenerative medicine, governments in several regions have started to provide public support for regenerative medicine programs such as stem cell research, development of biomaterials, and tissue engineering.

In July 2015, the city of Gamagori in Japan’s Aichi Prefecture became the first in the country to have a government-run local hospital with a Certified Special Committee for Regenerative Medicine. This is expected to provide a boost to the rising medical technology sector in the city. Many cities and government hospitals in Japan could adopt the same supportive attitude if Gamagori’s venture goes well.

Ethical Issues with Stem Cell Usage Restraining Regenerative Medicines Market

Stem cell therapy is a major part of the regenerative medicines market. However, usage of stem cells is shrouded in ethical issues, due to the unfortunate association in public perception between stem cell usage and abortion. As a result, adult stem cells have grown prominent in the stem cell research sector in recent years. Rising acknowledgment of the importance of stem cell therapy in regenerative medicine will help regenerative medicine researchers overcome this barrier.

Browse Press Release: http://www.transparencymarketresearch.com/pressrelease/regenerative-medicines-market.htm

The risk of post-implant rejection of biomaterials and engineered tissue is also an important factor in regenerative medicine procedures. Since regenerative medicine is necessarily bioactive, there is a risk of the patient’s body rejecting the foreign object. This risk has been minimized to a great degree over the years, but still remains a significant restraint on the regenerative medicines market. However, this is expected to be a heavily researched topic in the coming years and a viable solution is sure to be found, ensuring steady development of the global regenerative medicines market in the coming years.